Use and Cost of First-Line Biologic Medications to Treat Plaque Psoriasis in the US
This cross-sectional study found that from 2007 to 2021, treatment costs increased for biologic medications used to treat plaque psoriasis. Substantial savings are available if more patients and physicians use the lowest-cost options and/or if drug prices were better aligned with the comparative effectiveness and safety of each medication.
Authors
- Helen Mooney
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Benjamin N. Rome (ORCID: https://orcid.org/0000-0001-5776-3293)
- Jiali Han (ORCID: https://orcid.org/0009-0005-6068-0188)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1001/jamadermatol.2025.0669
- Citations
- 9
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 7.18